R.S.V. Vaccines May Slightly Increase Risk of Rare Neurological Conditionnews2024-02-29T22:20:23+00:00February 29th, 2024|The New York Times|
R.S.V. Shot for Infants Is in Short Supply: What to Knownews2023-10-25T02:29:27+00:00October 25th, 2023|The New York Times|
Do Early R.S.V. Vaccine Trials Have a Henrietta Lacks Story?news2023-10-11T23:00:12+00:00October 11th, 2023|The New York Times|
New RSV Vaccines Aren’t Covered by Some Health Insurance Plansnews2023-08-25T19:55:21+00:00August 25th, 2023|The New York Times|
RSV Vaccines: What to Know For Babies, Pregnant Women and Older Adultsnews2023-08-21T09:00:31+00:00August 21st, 2023|The New York Times|
FDA Panel Recommends RSV Shot to Protect Infantsnews2023-06-08T20:11:09+00:00June 8th, 2023|The New York Times|
FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Oldernews2023-05-31T22:35:58+00:00May 31st, 2023|The New York Times|
FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
